T.C. Orton

1.7k total citations
40 papers, 1.4k citations indexed

About

T.C. Orton is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, T.C. Orton has authored 40 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 14 papers in Pharmacology and 10 papers in Oncology. Recurrent topics in T.C. Orton's work include Pharmacogenetics and Drug Metabolism (11 papers), Drug Transport and Resistance Mechanisms (5 papers) and Peroxisome Proliferator-Activated Receptors (3 papers). T.C. Orton is often cited by papers focused on Pharmacogenetics and Drug Metabolism (11 papers), Drug Transport and Resistance Mechanisms (5 papers) and Peroxisome Proliferator-Activated Receptors (3 papers). T.C. Orton collaborates with scholars based in United Kingdom, United States and Singapore. T.C. Orton's co-authors include Oliver Flint, R.D. Pickett, M. Anderson, Thomas E. Eling, Peter Greaves, Graham R. Nunn, J.C. Topham, M. Kay Washington, Gerald R. Hankins and Robert L. Fine and has published in prestigious journals such as Environmental Health Perspectives, Journal of Pharmacology and Experimental Therapeutics and British Journal of Pharmacology.

In The Last Decade

T.C. Orton

37 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
T.C. Orton United Kingdom 16 633 292 274 271 244 40 1.4k
Carl L. Alden United States 22 397 0.6× 180 0.6× 175 0.6× 441 1.6× 115 0.5× 65 1.4k
Jaspreet S. Sidhu United States 21 879 1.4× 476 1.6× 256 0.9× 208 0.8× 139 0.6× 34 1.6k
Christoph Köhle Germany 25 1.1k 1.7× 411 1.4× 343 1.3× 395 1.5× 157 0.6× 38 2.3k
J. D. Tange Australia 24 376 0.6× 382 1.3× 192 0.7× 109 0.4× 102 0.4× 77 1.9k
David S. Riddick Canada 19 587 0.9× 556 1.9× 343 1.3× 377 1.4× 218 0.9× 54 1.8k
John G. DeLuca United States 21 1.0k 1.6× 161 0.6× 294 1.1× 574 2.1× 51 0.2× 37 1.8k
Alison E.M. Vickers United States 23 443 0.7× 503 1.7× 330 1.2× 126 0.5× 56 0.2× 55 1.5k
Μartine Aggerbeck France 25 679 1.1× 156 0.5× 209 0.8× 124 0.5× 133 0.5× 59 1.6k
Peter Münzel Germany 22 507 0.8× 553 1.9× 397 1.4× 232 0.9× 101 0.4× 38 1.3k
David R. Plowchalk United States 20 270 0.4× 330 1.1× 264 1.0× 149 0.5× 86 0.4× 27 1.4k

Countries citing papers authored by T.C. Orton

Since Specialization
Citations

This map shows the geographic impact of T.C. Orton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T.C. Orton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T.C. Orton more than expected).

Fields of papers citing papers by T.C. Orton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T.C. Orton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T.C. Orton. The network helps show where T.C. Orton may publish in the future.

Co-authorship network of co-authors of T.C. Orton

This figure shows the co-authorship network connecting the top 25 collaborators of T.C. Orton. A scholar is included among the top collaborators of T.C. Orton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T.C. Orton. T.C. Orton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sidaway, James E., et al.. (2009). Statin-induced myopathy in the rat: relationship between systemic exposure, muscle exposure and myopathy. Xenobiotica. 39(1). 90–98. 22 indexed citations
2.
3.
Tucker, Mary J., et al.. (1996). CARCINOGENESIS: Carcinogenicity of cyproterone acetate in the mouse. Carcinogenesis. 17(7). 1473–1476. 9 indexed citations
4.
Stanley, Lesley A., Dana Blackburn, Julie F. Foley, et al.. (1994). Ras mutations in methyiclofenapate-induced B6C3F1 and C57BL/1OJ mouse liver tumours. Carcinogenesis. 15(6). 1125–1131. 15 indexed citations
5.
Barrass, Nigel, M. Stewart, Sarah Warburton, et al.. (1993). Cell proliferation in the liver and thyroid of C57Bl/10J mice after dietary administration of chlordane.. Environmental Health Perspectives. 101(suppl 5). 219–223. 15 indexed citations
6.
Greaves, Peter, et al.. (1993). Two-year carcinogenicity study of tamoxifen in Alderley Park Wistar-derived rats.. PubMed. 53(17). 3919–24. 249 indexed citations
7.
Barrass, Nigel, Roger J. Price, Brian G. Lake, & T.C. Orton. (1993). Comparison of the acute and chronic mitogenic effects of the peroxisome proliferators methylclofenapate and clofibric acid in rat liver. Carcinogenesis. 14(7). 1451–1456. 52 indexed citations
8.
9.
Lewis, David F., et al.. (1989). Teratogenicity of phenylhydantoins in an in vitro system: Molecular orbital-generated quantitative structure-toxicity relationships. Xenobiotica. 19(12). 1471–1481. 11 indexed citations
10.
11.
Duffy, Paul, et al.. (1986). Initial validation of an In vitro test for predicting skin irritancy. Food and Chemical Toxicology. 24(6-7). 517–518. 10 indexed citations
12.
Rhodes, Christopher J., et al.. (1986). Comparative pharmacokinetics and subacute toxicity of di(2-ethylhexyl) phthalate (DEHP) in rats and marmosets: extrapolation of effects in rodents to man.. Environmental Health Perspectives. 65. 299–307. 99 indexed citations
13.
Flint, Oliver & T.C. Orton. (1984). An in vitro assay for teratogens with cultures of rat embryo midbrain and limb bud cells. Toxicology and Applied Pharmacology. 76(2). 383–395. 164 indexed citations
14.
Bratt, H., et al.. (1983). The disposition of 14c-di-2-ethylhexylphthalate (dehp) in the marmoset and rat. Toxicology Letters. 18. 64–64. 1 indexed citations
15.
Lowery, Colin A., T.C. Orton, & R. Colin Garner. (1983). Metabolic activation and bacterial mutagenicity of aflatoxin B1 in two different test systems. Toxicology. 29(1-2). 131–141.
16.
Orton, T.C. & Colin A. Lowery. (1981). Practolol metabolism. III. Irreversible binding of [14C]practolol metabolite(s) to mammalian liver microsomes.. Journal of Pharmacology and Experimental Therapeutics. 219(1). 207–212. 7 indexed citations
17.
Case, David, et al.. (1978). Metabolism studies with practolol [proceedings].. PubMed. 63(2). 352P–352P. 2 indexed citations
18.
Orton, T.C., Colin A. Lowery, & W E Lindup. (1977). Irreversible protein binding of [14C]-practolol metabolite(s) to hamster liver microsomes (proceedings).. PubMed. 60(2). 319P–319P. 1 indexed citations
19.
Pickett, R.D., M. Anderson, T.C. Orton, & Thomas E. Eling. (1975). The pharmacodynamics of 5-hydroxytryptamine uptake and metabolism by the isolated perfused rabbit lung.. Journal of Pharmacology and Experimental Therapeutics. 194(3). 545–553. 32 indexed citations
20.
Nicholls, Paul J. & T.C. Orton. (1971). Absorption, distribution and excretion of methsuximide in male rats.. PubMed. 43(2). 459P–460P. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carl L. Alden Breakdown of academic impact, for papers by Jaspreet S. Sidhu Breakdown of academic impact, for papers by Christoph Köhle Breakdown of academic impact, for papers by J. D. Tange Breakdown of academic impact, for papers by David S. Riddick Breakdown of academic impact, for papers by John G. DeLuca Breakdown of academic impact, for papers by Alison E.M. Vickers Breakdown of academic impact, for papers by Μartine Aggerbeck Breakdown of academic impact, for papers by Peter Münzel Breakdown of academic impact, for papers by David R. Plowchalk
Rankless by CCL
2026